A potential role for the acid-sensing T cell death associated gene-8 (TDAG8) receptor in depression-like behavior

Physiology and Behavior

Volumn 150, Issue , 2015, Pages 78-82

  Vollmer, Lauren Larke ^a   Schmeltzer, Sarah N ^a   Ahlbrand, Rebecca ^a   Sah, Renu ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Behavior; Depression; T cell death associated gene 8; TDAG8

Indexed keywords

G PROTEIN COUPLED RECEPTOR; SUCROSE; T CELL DEATH ASSOCIATED GENE 8 RECEPTOR; UNCLASSIFIED DRUG; ENHANCED GREEN FLUORESCENT PROTEIN; GPCR25 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; SWEETENING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BEHAVIOR CHANGE; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FORCED SWIM TEST; GENETIC ASSOCIATION; GENOTYPE; IMMOBILITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATION; LOCOMOTION; MOTOR ACTIVITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ANALYSIS OF VARIANCE; ANIMAL; BAGG ALBINO MOUSE; DISEASE MODEL; DRINKING; EATING; FOOD PREFERENCE; GENETICS; METABOLISM; PSYCHOLOGY; SWIMMING; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; DRINKING; EATING; FOOD PREFERENCES; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOTOR ACTIVITY; RECEPTORS, G-PROTEIN-COUPLED; SUCROSE; SWEETENING AGENTS; SWIMMING;

EID: 84939565245     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.03.012     Document Type: Article

References (65)

1. Greden J.F. The burden of disease for treatment-resistant depression. J. Clin. Psychiatry 2001, 62. (26-31+35).
2. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997, 349:1498-1504.
3. Lépine J.-P., Briley M. The increasing burden of depression. Neuropsychiatr. Dis. Treat. 2011, 7:3-7.
4. Miret M., Ayuso-Mateos J.L., Sanchez-Moreno J., Vieta E. Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci. Biobehav. Rev. 2013, 37:2372-2374.
5. Bobo W.V., et al. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. J. Affect. Disord. 2011, 133:467-476.
6. Khan A., Faucett J., Lichtenberg P., Kirsch I., Brown W.A. A systematic review of comparative efficacy of treatments and controls for depression. PLoS One 2012, 7:e41778.
7. Souery D., Papakostas G.I., Trivedi M.H. Treatment-resistant depression. J. Clin. Psychiatry 2006, 67(Suppl. 6):16-22.
8. Trivedi M.H., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry 2006, 163:28-40.
9. Werner F.-M., Coveñas R. Classical neurotransmitters and neuropeptides involved in major depression in a multi-neurotransmitter system: a focus on antidepressant drugs. Curr. Med. Chem. 2013, 20:4853-4858.
10. Werner F.-M., Coveñas R. Classical neurotransmitters and neuropeptides involved in major depression: a review. Int. J. Neurosci. 2010, 120:455-470.
11. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
12. Rosenblat J.D., Cha D.S., Mansur R.B., McIntyre R.S. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 53:23-34.
13. Pace T.W.W., Miller A.H. Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Ann. N. Y. Acad. Sci. 2009, 1179:86-105.
14. Iwata M., Ota K.T., Duman R.S. The inflammasome: pathways linking psychological stress, depression, and systemic illnesses. Brain Behav. Immun. 2013, 31:105-114.
15. Maes M., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
16. Maier S.F., Watkins L.R., Fleshner M. Psychoneuroimmunology: the interface between behavior, brain, and immunity. Am. Psychol. 1994, 49:1004-1017.
17. Anisman H., Ravindran A.V., Griffiths J., Merali Z. Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biol. Psychiatry 1999, 46:1649-1655.
18. Tuglu C., Kara S.H., Caliyurt O., Vardar E., Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berlin) 2003, 170:429-433.
19. Kim Y.-K., et al. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1044-1053.
20. Yang K., et al. Levels of serum interleukin (IL)-6, IL-1beta, tumour necrosis factor-alpha and leptin and their correlation in depression. Aust. N. Z. J. Psychiatry 2007, 41:266-273.
21. Dowlati Y., et al. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67:446-457.
22. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom. Med. 2009, 71:171-186.
23. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
24. Schiepers O.J.G., Wichers M.C., Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:201-217.
25. Felger J.C., Lotrich F.E. Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications. Neuroscience 2013, 246:199-229.
26. Kaster M.P., Gadotti V.M., Calixto J.B., Santos A.R.S., Rodrigues A.L.S. Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology 2012, 62:419-426.
27. Tarr A.J., Chen Q., Wang Y., Sheridan J.F., Quan N. Neural and behavioral responses to low-grade inflammation. Behav. Brain Res. 2012, 235:334-341.
28. Tynan R.J., et al. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav. Immun. 2012, 26:469-479.
29. Ohgi Y., Futamura T., Kikuchi T., Hashimoto K. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol. Biochem. Behav. 2013, 103:853-859.
30. Choi J.W., Lee S.Y., Choi Y. Identification of a putative G protein-coupled receptor induced during activation-induced apoptosis of T cells. Cell. Immunol. 1996, 168:78-84.
31. Ishii S., Kihara Y., Shimizu T. Identification of T cell death-associated gene 8 (TDAG8) as a novel acid sensing G-protein-coupled receptor. J. Biol. Chem. 2005, 280:9083-9087.
32. Ludwig M., et al. Proton-sensing G-protein-coupled receptors 2003, 425:93-98.
33. Radu C.G., Nijagal A., McLaughlin J., Wang L., Witte O.N. Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1632-1637.
34. Wang J.-Q., et al. TDAG8 is a proton-sensing and psychosine-sensitive G-protein-coupled receptor. J. Biol. Chem. 2004, 279:45626-45633.
35. McGuire J., et al. Acid-sensing by the T cell death-associated gene 8 (TDAG8) receptor cloned from rat brain. Biochem. Biophys. Res. Commun. 2009, 386:420-425.
36. Kyaw H., et al. Cloning, characterization, and mapping of human homolog of mouse T-cell death-associated gene. DNA Cell Biol. 1998, 17:493-500.
37. Radu C.G., et al. Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-cell death-associated gene 8 receptor. Mol. Cell. Biol. 2006, 26:668-677.
38. Chen Y.-J., Huang C.-W., Lin C.-S., Chang W.-H., Sun W.-H. Expression and function of proton-sensing G-protein-coupled receptors in inflammatory pain. Mol. Pain 2009, 5:39.
39. Okajima F. Regulation of inflammation by extracellular acidification and proton-sensing GPCRs. Cell. Signal. 2013, 25:2263-2271.
40. Huang C.-W., et al. Nociceptors of dorsal root ganglion express proton-sensing G-protein-coupled receptors. Mol. Cell. Neurosci. 2007, 36:195-210.
41. Kottyan L.C., et al. Eosinophil viability is increased by acidic pH in a cAMP- and GPR65-dependent manner. Blood 2009, 114:2774-2782.
42. Vollmer L.E., et al. Attenuated stress-evoked anxiety, increased sucrose preference and delayed spatial learning in glucocorticoid-induced receptor-deficient mice. Genes Brain Behav. 2013, 12:241-249.
43. Can A., et al. The mouse forced swim test. J. Vis. Exp. 2012, e3638. 10.3791/3638.
44. Solomon M.B., et al. Deletion of forebrain glucocorticoid receptors impairs neuroendocrine stress responses and induces depression-like behavior in males but not females. Neuroscience 2012, 203:135-143.
45. Karp C.L. Unstressing intemperate models: how cold stress undermines mouse modeling. J. Exp. Med. 2012, 209:1069-1074.
46. Pliakas A.M., et al. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J. Neurosci. 2001, 21:7397-7403.
47. Solomon M.B., et al. The selective glucocorticoid receptor antagonist CORT 108297 decreases neuroendocrine stress responses and immobility in the forced swim test. Horm. Behav. 2014, 65:363-371.
48. Slattery D.A., Cryan J.F. Using the rat forced swim test to assess antidepressant-like activity in rodents. Nat. Protoc. 2012, 7:1009-1014.
49. Jin Y., et al. Inhibition of interleukin-1β production by extracellular acidification through the TDAG8/cAMP pathway in mouse microglia. J. Neurochem. 2014, 10.1111/jnc.12661.
50. Vollmer L.L., Bailey L., Li K.-Y., Lewkowich I., Putnam R.W., Sah R. Microglial acid-sensing t-cell death associated gene-8 (tdag8) receptor: linking neuroinflammation and panic responses. Soc. Neuroscience Abstr. 2013.
51. Bergink V., Gibney S.M., Drexhage H.A. Autoimmunity, inflammation, and psychosis: a search for peripheral markers. Biol. Psychiatry 2014, 75:324-331.
52. Lawson M.A., McCusker R.H., Kelley K.W. Interleukin-1 beta converting enzyme is necessary for development of depression-like behavior following intracerebroventricular administration of lipopolysaccharide to mice. J. Neuroinflammation 2013, 10:54.
53. Chourbaji S., et al. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol. Dis. 2006, 23:587-594.
54. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:751-756.
55. Simen B.B., Duman C.H., Simen A.A., Duman R.S. TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biol. Psychiatry 2006, 59:775-785.
56. Godbout J.P., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
57. Dunn A.J., Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacol. Biochem. Behav. 2005, 81:688-693.
58. Deak T., et al. Behavioral responses during the forced swim test are not affected by anti-inflammatory agents or acute illness induced by lipopolysaccharide. Behav. Brain Res. 2005, 160:125-134.
59. Deak T., Bellamy C., D'Agostino L.G. Exposure to forced swim stress does not alter central production of IL-1. Brain Res. 2003, 972:53-63.
60. Coryell M.W., et al. Acid-sensing ion channel-1a in the amygdala, a novel therapeutic target in depression-related behavior. J. Neurosci. 2009, 29:5381-5388.
61. Aoi W., Marunaka Y. Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transport. BioMed Res. Int. 2014, 2014:598986.
62. Rajamäki K., et al. Extracellular acidosis is a novel danger signal alerting innate immunity via the NLRP3 inflammasome. J. Biol. Chem. 2013, 288:13410-13419.
63. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 1997, 134:319-329.
64. Badgaiyan R.D., Mandal M.B. Alterations of ventricular pH alter water intake and food consumption in rats. Physiol. Behav. 1990, 47:489-492.
65. Walker A.J., et al. Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention. Front. Psychiatry 2014, 5:34.